16 April 2019 Ankylosing Spondylitis Biologics EULAR Game-changing RA drugs out of Third World’s reach
16 April 2019 Ankylosing Spondylitis Biologics Biosimilar launch will make affordable rituximab a reality
28 March 2019 Analgesics Biologics Conditions Corticosteroids Spondyloarthritis Take only as directed: high-dose Xeljanz poses PE risk
18 March 2019 Analgesics Conditions Polymyalgia Rheumatica The mysterious connection between sleep apnoea and gout
18 March 2019 APLAR Conditions Global Health Patient Perspective Strep A bacteria kill half a million a year. Why don’t we have a vaccine?
6 March 2019 Ankylosing Spondylitis Biologics Conditions Scleroderma New biologics for psoriatic arthritis
